“Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma” has been added to your cart. View cart

Article: P.68 Heterosexual HIV-1 Transmission is Associated with Allogeneic KIR/HLA Ligand Combinations Governing Natural Killer Cell Alloreactivity

€3.03

SKU: product-article-21300 Category: General

Description
Reviews (0)

Description

P.68 Heterosexual HIV-1 Transmission is Associated with Allogeneic KIR/HLA Ligand Combinations Governing Natural Killer Cell Alloreactivity

Top

Article: P.68 Heterosexual HIV-1 Transmission is Associated with Allogeneic KIR/HLA Ligand Combinations Governing Natural Killer Cell Alloreactivity

Description

Reviews

Related products

Article: Highlights in melanoma

Article: INTRODUCTION

1 year subscription print edition of the Belgian Journal of Hematology (BJH)

Article: Calendar of events